Vladimir Jovasevic, Ph.D.
Affiliations: | 2004 | University of Illinois at Chicago, Health Sciences Center, Chicago, IL 60612, United States |
Area:
Biochemistry, Immunology, Molecular Biology, OncologyGoogle:
"Vladimir Jovasevic"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Margalit B. Mokyr | grad student | 2004 | University of Illinois at Chicago, Health Sciences Center | |
| (Mechanism of potentiation of tumor -eradicating immunity by melphalan and by CTLA-4 blockade.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Guedea AL, Schrick C, Guzman YF, et al. (2011) ERK-associated changes of AP-1 proteins during fear extinction. Molecular and Cellular Neurosciences. 47: 137-44 |
| Jovasevic V, Liang L, Roizman B. (2008) Proteolytic cleavage of VP1-2 is required for release of herpes simplex virus 1 DNA into the nucleus. Journal of Virology. 82: 3311-9 |
| Jovasevic VM, Gorelik L, Bluestone JA, et al. (2004) Importance of IL-10 for CTLA-4-mediated inhibition of tumor-eradicating immunity. Journal of Immunology (Baltimore, Md. : 1950). 172: 1449-54 |
| Donepudi M, Jovasevic VM, Raychaudhuri P, et al. (2003) Melphalan-induced up-regulation of B7-1 surface expression on normal splenic B cells. Cancer Immunology, Immunotherapy : Cii. 52: 162-70 |
| Jovasevic VM, Mokyr MB. (2001) Melphalan-induced expression of IFN-beta in MOPC-315 tumor-bearing mice and its importance for the up-regulation of TNF-alpha expression. Journal of Immunology (Baltimore, Md. : 1950). 167: 4895-901 |